The clinical outcome and disease severity in coronavirus disease 2019 (COVID-19) are
heterogeneous, and the progression or fatality of the disease cannot be explained by a …

Viruses hijack host metabolic pathways for their replicative advantage. In this study, using
patient-derived multiomics data and in vitro infection assays, we aimed to understand the …

The post-acute sequelae of COVID-19 (PASC), also known as long COVID, is often
associated with debilitating symptoms and adverse multisystem consequences. We obtain …

The Corona Virus Disease 2019 (COVID-19) pandemic represents an ongoing worldwide
challenge. The present large study sought to understand independent and overlapping …

The current pandemic of coronavirus disease 2019 (COVID-19) has affected> 160 million
individuals to date, and has caused millions of deaths worldwide, at least in part due to the …

Viral sepsis has been proposed as an accurate term to describe all multisystemic
dysregulations and clinical findings in severe and critically ill COVID-19 patients. The …

A better understanding of the metabolic alterations in immune cells during severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may elucidate the wide diversity …

Severe manifestations of coronavirus disease 2019 (COVID-19) and mortality have been
associated with physiological alterations that provide insights into the pathogenesis of the …

Although immune dysfunction is a key feature of coronavirus disease 2019 (COVID-19), the
metabolism-related mechanisms remain elusive. Here, by reanalyzing single-cell RNA …

Deep understanding of the SARS-CoV-2 effects on host molecular pathways is paramount
for the discovery of early biomarkers of outcome of coronavirus disease 2019 (COVID-19) …